Misophonia Successfully Treated of With Fluoxetine: A Case Report
Conclusions
Fluoxetine may be used as an effective drug in the treatment of misophonia. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Treatment of Severe Excoriation Disorder With Mirtazapine: A Case Report
Conclusion
Mirtazapine is a noradrenergic and specific serotonergic antidepressant, and its antihistaminergic effect can relieve skin itching and pain. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Levosulpiride Relieved Persistent Hiccups in a Patient With COVID-19 and Vascular Cognitive Impairment
Conclusions
Oral levosulpiride is a suitable option in persistent hiccups that occur in patients with COVID-19 pneumonia. To our knowledge, this is the fourth published case of persistent hiccups as a clinical feature of COVID-19. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Lamotrigine for Treating Anger in Veterans With Posttraumatic Stress Disorder
Lamotrigine is an antiepileptic drug that was Food and Drug Administration approved in 2003 for use in the maintenance treatment of bipolar I disorder to delay the time to recurrence of new mood episodes. The mechanism by which lamotrigine achieves its therapeutic effect in the treatment of bipolar disorder is unknown. Here, we report on 2 Veterans with combat-related posttraumatic stress disorder (PTSD) endorsing significant anger, aggression, and agitation, who were treated with selective serotonin reuptake inhibitors, but whose residual symptoms of anger and aggression were ultimately successfully managed with lamotrigi...
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Behavioral and Cognitive Response to Selective Serotonin Reuptake Inhibitors in Frontotemporal Lobar Degeneration: A Systematic Review and Meta-analysis
Conclusions
The current meta-analysis supports SSRIs as an intervention for management of behavioral symptoms of FTLD. Marked improvements were seen in disinhibition, irritability, aggression, and aberrant motor activity across studies. However, apathy/loss of empathy did not show similarly promising results. A deteriorative effect on cognition was seen associated with SSRI use. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Review Article Source Type: research
Real World Pharmacological First Treatment Patterns of Patients With Parkinson Disease and Disease Duration: A Large-Scale Cohort Study Using an Health Maintenance Organization Database
Conclusions
First antiparkinsonian drug choice might be associated with time until l-DOPA initiation but may represent disease severity at the time of prescription, thus also affecting survival time as well. Real-world data illustrated that this choice is also age and sex dependent. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Original Articles Source Type: research
Efficacy and Safety of Intranasal Dexmedetomidine During Recovery From Sevoflurane Anesthesia in Children: A Systematic Review and Meta-analysis
Background
Intranasal drip of dexmedetomidine in children with sevoflurane anesthesia can reduce anesthesia and restlessness. However, there is still some controversy. We conducted a meta-analysis to explore the effect of intranasal infusion of dexmedetomidine on the quality of recovery during the recovery period, to provide certain guidance for clinical application.
Methods
Web of Science, PubMed, Embase, and the Cochrane Library were used for literature search. Systematic reviews were based on PRISMA (the Preferred Reporting Items for Systematic Reviews and Meta-Analysis).
Results
A total of 14 articles...
Source: Clinical Neuropharmacology - September 1, 2021 Category: Neurology Tags: Original Articles Source Type: research
Delayed-Onset Serotonin Syndrome Is Not Unusual With Linezolid
No abstract available (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research
Steroids With Risperidone: Is it Really a New Frontier in the Treatment of Autism Spectrum Disorders Among Children and Adolescents?
No abstract available (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research
Lithium-Induced Treatment-Resistant Akathisia: A Case Report and Literature Overview
Discussion
Akathisia is commonly overlooked or misdiagnosed by physicians. This case report is presented to alert physicians to the possible emergence of akathisia when the lithium ion is prescribed for mood stabilization. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Trazodone Treatment of Bruxism in a Patient With Severe Dementia
Conclusions
Bruxism is occasionally encountered in patients with advanced dementia and raises concerns about nutritional compromise and about potential need for poorly tolerated dental treatment. Trazodone may potentially be effective for bruxism in some patients. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Low-Dose Aripiprazole-Induced Nocturnal Enuresis in a 9-Year-Old Boy: A Case Report and the Possible Underlying Mechanism
In this report, we present the case of a 9-year-old boy who developed nocturnal enuresis after the beginning of low-dose aripiprazole treatment. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Oseltamivir-Induced Mania in a Patient With Influenza A
Oseltamivir is an antiviral drug often preferred in treating viral infections. Its use has increased owing to annual influenza outbreaks and the COVID-19 pandemic. Although its adverse effects are often seen in the gastrointestinal system, it has other adverse effects that can prevent its use, for example, neuropsychiatric events. In this case report, we present a manic episode case caused by the use of oseltamivir. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Excessive Masturbation Successfully Treated With Methylphenidate in a 6-Year-Old Child With Autism Spectrum Disorder Accompanied by Attention Deficit Hyperactivity Disorder
Children with autism spectrum disorder frequently exhibit inappropriate sexual behaviors, such as excessive masturbation. However, research on the control and management of excessive masturbation in these children is very limited. In this presentation, excessive masturbation that responded to treatment with methylphenidate is described in a young boy diagnosed with autism spectrum disorder and comorbid attention deficit hyperactivity disorder. (Source: Clinical Neuropharmacology)
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
Activation Syndrome in a Patient With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine: A Case Report
“Activation syndrome” represents a cluster of symptoms of excessive emotional arousal or behavioral activation, which emerges after the first few weeks of antidepressant treatment or a dose increase and resolves with dose reduction or cessation of treatment. It was reported after treatment with selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor group of agents, but no case of activation syndrome has been reported with the norepinephrine reuptake inhibitor group. Atomoxetine is a norepinephrine reuptake inhibitor and nonstimulant and is used to manage symptoms of attention-deficit/hyp...
Source: Clinical Neuropharmacology - May 1, 2021 Category: Neurology Tags: Case Reports Source Type: research
